Alzamend Neuro (ALZN) Short Interest Ratio & Short Volume → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ALZN Stock Alerts $0.63 -0.02 (-3.06%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Alzamend Neuro Short Interest DataCurrent Short Volume22,500 sharesPrevious Short Volume14,500 sharesChange Vs. Previous Month+55.17%Dollar Volume Sold Short$15,997.50Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares6,880,000 sharesFloat Size4,830,000 sharesShort Percent of Float0.47%Today's Trading Volume31,506 sharesAverage Trading Volume64,085 sharesToday's Volume Vs. Average49% Short Selling Alzamend Neuro ? Sign up to receive the latest short interest report for Alzamend Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatALZN Short Interest Over TimeALZN Days to Cover Over TimeALZN Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Alzamend Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202422,500 shares $15,997.50 +55.2%0.5%0.3 $0.71 4/15/202414,500 shares $10,745.23 -68.0%0.3%0.3 $0.74 3/31/202445,300 shares $45,300.00 -11.5%0.9%0.8 $1.00 3/15/202451,200 shares $47,616.00 +13.0%1.0%0.9 $0.93 2/29/202445,300 shares $40,770.00 +2.5%0.9%0.7 $0.90 2/15/202444,200 shares $39,019.76 +4.5%0.9%0.8 $0.88 Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 1/31/202442,300 shares $36,378.00 -41.5%0.9%0.3 $0.86 1/15/202472,300 shares $70,449.12 -2.8%1.9%0.5 $0.97 12/31/202374,400 shares $66,216.00 -43.5%2.1%0.6 $0.89 12/15/2023131,700 shares $131,700.00 -29.5%3.7%1 $1.00 11/30/2023186,900 shares $226,149.00 +379.2%5.7%1.6 $1.21 11/15/202339,000 shares $58,500.00 -18.2%1.2%0.4 $1.50 10/31/202347,700 shares $1.25 million -92.1%1.5%2.3 $26.26 10/15/2023602,000 shares $124,012.00 +30.0%1.2%2.8 $0.21 9/30/2023463,200 shares $109,778.40 +82.8%1.0%2.2 $0.24 9/15/2023253,400 shares $60,816.00 +17.3%0.5%1.3 $0.24 8/31/2023216,000 shares $56,635.20 -60.7%0.4%1.2 $0.26 8/15/2023549,900 shares $169,919.10 +8.9%1.2%2.8 $0.31 7/31/2023505,200 shares $228,855.60 +2.6%1.1%3 $0.45 7/15/2023492,500 shares $247,235.00 +4.0%1.1%3.1 $0.50 6/30/2023473,700 shares $241,587.00 +13.0%1.1%2.9 $0.51 6/15/2023419,400 shares $285,192.00 -44.9%0.9%2.5 $0.68 5/31/2023761,400 shares $552,928.68 +44.0%1.7%4.2 $0.73 5/15/2023528,600 shares $274,713.42 -11.1%1.2%3.2 $0.52 4/30/2023594,400 shares $325,315.12 -8.6%1.3%3.5 $0.55 4/15/2023650,500 shares $382,038.65 +10.9%1.4%3.4 $0.59 3/31/2023586,500 shares $249,262.50 -18.2%1.3%2.9 $0.43 3/15/2023717,000 shares $343,729.80 -0.4%1.6%2.4 $0.48 2/28/2023719,600 shares $386,353.24 +5.1%1.6%2.4 $0.54 2/15/2023685,000 shares $401,478.50 -31.1%1.5%2.2 $0.59 1/31/2023994,100 shares $659,784.17 +11.2%2.2%2.8 $0.66 1/15/2023893,700 shares $529,964.10 -44.8%2.0%2.5 $0.59 12/30/20221,620,000 shares $915,138.00 +3.2%4.5%4.4 $0.56 12/15/20221,570,000 shares $1.40 million -7.7%4.4%3.6 $0.89 11/30/20221,700,000 shares $1.96 million -20.6%5.8%3.3 $1.15 11/15/20222,140,000 shares $2.40 million +27.4%7.3%4 $1.12 10/31/20221,680,000 shares $1.97 million -11.1%5.4%2.9 $1.17 10/15/20221,890,000 shares $1.98 million -34.2%5.5%3.1 $1.05 9/30/20222,870,000 shares $3.42 million +221.9%8.4%4.8 $1.19 9/15/2022891,700 shares $1.11 million -33.0%2.6%1.9 $1.24Make this ONE trade on Tuesday at 2 p.m. EST! (Ad)Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!Discover The Secret Loophole BEFORE Tuesday! ALZN Short Interest - Frequently Asked Questions What is Alzamend Neuro's current short interest? Short interest is the volume of Alzamend Neuro shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 22,500 shares of ALZN short. 0.47% of Alzamend Neuro's shares are currently sold short. Learn More on Alzamend Neuro's current short interest. Which institutional investors are shorting Alzamend Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Alzamend Neuro: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Alzamend Neuro? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.47% of Alzamend Neuro's floating shares are currently sold short. Is Alzamend Neuro's short interest increasing or decreasing? Alzamend Neuro saw a increase in short interest in April. As of April 30th, there was short interest totaling 22,500 shares, an increase of 55.2% from the previous total of 14,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alzamend Neuro's float size? Alzamend Neuro currently has issued a total of 6,880,000 shares. Some of Alzamend Neuro's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alzamend Neuro currently has a public float of 4,830,000 shares. How does Alzamend Neuro's short interest compare to its competitors? 0.47% of Alzamend Neuro's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Alzamend Neuro: Cyclacel Pharmaceuticals, Inc. (29.26%), Petros Pharmaceuticals, Inc. (3.25%), Exicure, Inc. (1.75%), Ensysce Biosciences, Inc. (0.14%), Soligenix, Inc. (6.22%), Tharimmune, Inc. (1.03%), Clever Leaves Holdings Inc. (2.03%), GT Biopharma, Inc. (0.48%), Seelos Therapeutics, Inc. (6.86%), ZyVersa Therapeutics, Inc. (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Alzamend Neuro stock? Short selling ALZN is an investing strategy that aims to generate trading profit from Alzamend Neuro as its price is falling. ALZN shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alzamend Neuro? A short squeeze for Alzamend Neuro occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALZN, which in turn drives the price of the stock up even further. How often is Alzamend Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALZN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Cyclacel Pharmaceuticals Short Interest Data Petros Pharmaceuticals Short Interest Data Exicure Short Interest Data Ensysce Biosciences Short Interest Data Soligenix Short Interest Data Tharimmune Short Interest Data Clever Leaves Short Interest Data GT Biopharma Short Interest Data Seelos Therapeutics Short Interest Data ZyVersa Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ALZN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace